Markets
THC

HNT Terminates Contract with Tenet - Analyst Blog

A generic image of many stacks of coins
Credit: Shutterstock photo

Yesterday, Health Net Inc. ( HNT ) announced that its subsidiaries have terminated their 3-year contract with 6 hospitals of Tenet Healthcare Corp. ( THC ) in Southern California. The contract termination resulted due to the inability of the companies to reach an agreement regarding the terms for extension. Health Net was in favor of changing the reimbursement rates offered by Tenet Healthcare considering the present market condition in California.

The company wanted to bring the reimbursement rate at par with the medical consumer price index, which currently exceeds the 3% mark. Additionally, Health Net wanted the reimbursement rate for those programs, which are financed by the state or federal government, to be based on the funding of these programs. However, these terms were not acceptable to Tenet Healthcare.

Consequently, the two companies failed to reach an agreement and Health Net decided to use its contractual option to terminate the agreements with all 6 Tenet Healthcare hospitals. The agreements have been terminated with effect from December 21, 2012. The company had agreements with Desert Regional Medical Center, Fountain Valley Hospital and Medical Center, John F. Kennedy Memorial Hospital, Lakewood Regional Medical Center, Los Alamitos Medical Center and Placentia Linda Hospital.

Health Net believes that the current reimbursement rates were not reasonable and increased the health care costs of its customers. The increasing cost went against the company's objective of providing reasonably priced health care to its clientele. Thus, it prematurely terminated the contract, which was already on the verge on expiration.

Both Health Net and Tenet Healthcare currently carry a Zacks #2 Rank (Buy). We also maintain a long-term 'Neutral' recommendation on the stocks.

HEALTH NET INC (HNT): Free Stock Analysis Report

TENET HEALTH (THC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

THC

Other Topics

Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More